The group’s principle activity is to provide innovative medical solutions that enable the treatment of patients with unmet clinical needs. The group also provides aquapheresis therapy. The group operates from United States.
Executive Information
Name
Title
Email
John Erb
Chmn.
N/A
David Springer
CEO, Pres.
N/A
Ronald Nelson
CFO
N/A
John Omahony
VP - Operations, Research & Development, RA and QA
